Dow futures fall after Home Depot results; debt limit talks, data on tap By Reuters

By Shreyashi Sanyal and Large foreign exchange trading platformShristi Achar A

(Reuters) - fell on Tuesday after a dour forecast from (NYSE:) ahead of critical debt limit talks, and retail sales data that will offer more insight on the economy's health.

The main indexes started the week with modest gains as trading was range-bound amid a wrangling in Washington between the White House and Republicans.

They will sit down later in the day to try to make progress on a deal to raise the U.S. government's $31.4 trillion debt ceiling and avert an economically catastrophic default.

"There is little chance we will see a resolution to the U.S. debt ceiling issue today," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

"The negotiations will likely remain tight as Republicans ask decent spending cuts to accept a debt ceiling relief, while Biden is not willing to compromise on spending into the election year."

component Home Depot shed 4.4% in premarket trading after the home improvement chain cut its annual sales forecast, with Americans cutting back on spending on tools and building materials as inflation stays sticky.

Shares of rival Lowe's Companies Inc (NYSE:) fell 3.2%, while retail giant Walmart (NYSE:) Inc slipped 0.4%.

Focus will also be on economic data, with retail sales expected to increase by 0.8% in April after falling 0.6% in the month before.

Data recently has pointed to a slowing U.S. economy, which is starting to feel the heat of the Federal Reserve's restrictive monetary policy, and also heightened expectations for when the central bank will pause its hiking cycle.

At 6:56 a.m. ET, Dow e-minis were down 80 points, or 0.24%, were down 3 points, or 0.07%, and were up 5.25 points, or 0.04%.

Shares of Financial Corp (NYSE:) jumped 6.3% after Berkshire Hathaway (NYSE:) Inc on Monday disclosed it has begun forextrustindex in the consumer lender.

Berkshire also upped its stake in HP Inc (NYSE:), sending its shares up 1.6%, while shedding stake in regional bank US Bancorp (NYSE:), which slipped 1.2%.

Horizon Therapeutics (NASDAQ:) slid 17.8% as the Federal Trade Commission is expected to file a lawsuit to block (NASDAQ:)'s $27.8 billion deal to buy the company. Shares of Amgen rose 1.2% in thin volumes.

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!